Pathological Biomarkers in Precision Medicine

Dear Colleagues,

In the dynamic landscape of precision medicine, this Special Issue seeks to comprehensively explore pathological biomarkers via multifaceted methods. The identification and validation of pathological biomarkers have emerged as critical components in tailoring therapeutic interventions for individual patients. This Special Issue invites contributions spanning a broad spectrum of research areas, including but not limited to the following:

• Biomarker Discovery and Validation: Research focusing on the identification, validation, and clinical translation of pathological biomarkers for various diseases, such as cancer, cardiovascular disorders, neurodegenerative diseases, and infectious diseases.
• Digital Biomarkers: Advancements in the identification and application of digital biomarkers, leveraging technologies for precise diagnostics and tailored therapeutic approaches.
• Omics Data Integration: Innovations in integrating multi-omics data (genomics, transcriptomics, proteomics, metabolomics, and phenomics) and clinical data for a holistic understanding of disease mechanisms and personalized treatment strategies.
• Digital Imaging Technologies: Advancements in medical imaging technologies, including radiomics, functional imaging, molecular imaging, computational pathology, and their role in refining diagnostics and biomarker detection.

We welcome original research articles and review papers that contribute to the deeper understanding of the importance of exploring more pathological biomarkers, with the ultimate goal of advancing precision medicine and improving patient outcomes.

Prof. Dr. Ovidiu Constantin Baltatu
Dr. Mirela A. Dobre
Dr. Tudor Groza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pathological biomarkers
• precision medicine
• artificial intelligence
• medical imaging
• omics data analysis
• personalized medicine
• biomarker discovery
• digital pathology